Circulating Levels of Neuroactive Steroids in Patients with Binge Eating Disorder: A Comparison with Nonobese Healthy Controls and Non-Binge Eating Obese Subjects

International Journal of Eating Disorders

Volumn 34, Issue 4, 2003, Pages 432-440

  Monteleone, Palmiero ^a   Luisi, Michele ^b   De Filippis, Gennaro ^a   Colurcio, Barbara ^a   Monteleone, Patrizia ^b   Genazzani, Andrea R ^b   Maj, Mario ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Allopregnenolone; Binge eating disorder; Dehydroepiandrosterone; Dehydroepiandrosterone sulphate; Eating disorders; Obesity

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; HYDROCORTISONE; PRASTERONE; PRASTERONE SULFATE; STEROID;

ADULT; ANOREXIA NERVOSA; ARTICLE; BINGE EATING DISORDER; BULIMIA; CLINICAL ARTICLE; CONTROLLED STUDY; EATING DISORDER; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; OBESITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STEROID BLOOD LEVEL;

ADULT; BULIMIA; CASE-CONTROL STUDIES; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; MULTIVARIATE ANALYSIS; OBESITY; PREGNANOLONE;

EID: 0242363331     PISSN: 02763478     EISSN: None     Source Type: Journal    
DOI: 10.1002/eat.10199     Document Type: Article

References (23)

1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
2. Baulieu, E.-E. (1996). Dehydroepiandrosterone (DHEA): A fountain of youth? Journal of Clinical Endocrinology and Metabolism, 81, 3147-3151.
3. A receptor. Brain Research, 561, 157-161.
4. Cole, T.J., Bellizzi, M.C., Flegal, K.M., & Dietz, W.H. (2000). Establishing a standard definition for child over-weight and obesity worldwide: International survey. British Medical Journal, 320, 1240-1243.
5. Couillard, C., Cagnon, J., Bergeron, J., Leon, A.S., Rao, D.C., Skinner, J.S., Wilmore, J.H., Despres, J.-P., & Bouchard, C. (2000). Contribution of body fatness and adipose tissue distribution to age variation in plasma steroid hormone concentrations in men: The HERITAGE family study. Journal of Clinical Endocrinology and Metabolism, 85, 1026-1031.
6. Deslypère, J.P., Vendonckm, L., & Vermeulenm, A. (1985). Fat tissue: A steroid reservoir and site of steroid metabolism. Journal of Clinical Endocrinology and Metabolism, 61, 564-570.
7. Dixon, J. (1985). BMDP statistical software. Berkeley: University of California Press.
8. First, M.B., Spitzer, R.L., Gibbon, M., & Williams, J.B. (1995). Structured Clinical Interview for DSM-IV axis I disorders-patient ed. (SCID-I/P, Version 2). New York: Biometrics Research Department.
9. Genazzani, A.R., Petraglia, F., Bernardi, F., Casarosa, E., Silvestroni, C., Tonotti, A., Nappi, P.E., Luisi, S., Palombo, M., Purdy, R.H., & Luisi, M. (1998). Circulating levels of allopregnanolone in humans: Gender, age, and endocrine influences. Journal of Clinical Endocrinology and Metabolism, 83, 2099-2103.
10. Maccario, M., Mazza, E., Ramunni, J., Oleandri, S.E., Savio, P., Grottoli, S., Rossetto, R., Procopio, M., Gauna, C., & Ghigo, E. (1999). Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women. Clinical Endocrinology, 50, 595-600.
11. Majewska, M.D., Harrison, N.L., Schwartz, R.D., Barker, J.L., & Paul, S.M. (1986). Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science, 232, 1004-1007.
12. Monteleone, P., Luisi, M., Colurcio, B., Casarosa, E., Monteleone, P., Ioime, R., Genazzani, A.R., & Maj, M. (2001). Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa. Psychosomatic Medicine, 63, 62-68.
13. Nestler, J.E., Beer, N.A., Jacubowicz, D.J., & Beer, R.M. (1994). Effects of reduction in circulating insulin by metformin on serum dehydroepiandrosterone sulphate in nondiabetic men. Journal of Clinical Endocrinology and Metabolism, 78, 549-554.
14. Nestler, J.E., Usiskin, K.S., Barlascini, C.O., Welty, D.F., Clore, J.N., & Blackard, W.G. (1989). Suppression of serum dehydroepiandrosterone sulphate levels by insulin: An evaluation of possible mechanisms. Journal of Clinical Endocrinology and Metabolism, 69, 1040-1046.
15. Parker, L.N., & Odell, W.D. (1980). Control of adrenal androgen secretion. Endocrine Review, 4, 392-410.
16. Pham, J., Porter, J., Svec, D., Eiswirth, C., & Svec, F. (2000). The effect of dehydroepiandrosterone on Zucker rats selected for fat food preference. Physiology and Behavior, 70, 431-441.
17. Reddy, D.S., & Kulkarni, S.K. (1998). The role of GABA-A and mitochondrial diazepam-binding inhibitor receptor on the effects of neurosteroids on food intake in mice. Psychopharmacology, 137, 391-400.
18. Rupprecht, R., & Holsboer, F. (1999). Neuroactive steroids: Mechanisms of action and neuropsychopharmacological perspectives. Trends in Neurosciences, 22, 410-416.
19. Taylor, A.E., Hubbard, J., & Anderson, E.J. (1999). Impact of binge eating on metabolic and leptin dynamics in normal young women. Journal of Clinical Endocrinology and Metabolism, 84, 428-434.
20. Wetzel, C.H., Hermann, B., Behl, C., Pestel, E., Rammes, G., Zieglgansberger, W., Holsboer, F., & Rupprecht, R. (1998). Functional antagonism of gonadal steroids at the 5-hydrotryptamine type 3 receptor. Molecular Endocrinology, 12, 1441-1451.
21. Wolkowitz, O.M., Reus, V.I., Keebler, A., Nelson, N., Friedland, M., Brizendine, L., & Roberts, E. (1999). Double-blind treatment of major depression with dehydroepiandrosterone. American Journal of Psychiatry, 156, 646-649.
22. World Health Organization (1998). Obesity: Preventing and managing the global epidemic: Report of a WHO consultation on obesity (WHO/NUT/NCD/98.1). Geneva: Author.
23. Zinder, O., & Dar, D.E. (1999). Neuroactive steroids: Their mechanism of action and their function in the stress response. Acta Physiologica Scandinavica, 167, 181-188.